We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immune Function Predicts Infection for Pediatric Trauma Patients

By LabMedica International staff writers
Posted on 23 Jul 2014
An immune marker that predicts which patients are likely to develop a hospital-acquired infection has been identified in critically ill children with traumatic injuries.

The clinical implementation of quick-turnaround immune function tests and treatments to prevent or reverse immune system damage following critical illness or injury in pediatric patients is essential. More...
This especially true where hospital-acquired, or nosocomial, infections pose a threat to any patient, but people who have suffered a traumatic injury are at the highest risk.

Clinical scientists at the Nationwide Children's Hospital (Columbus, OH, USA) collected blood samples from 21 healthy children and 76 critically injured children, 18 years of age or younger. In a test tube, they exposed each sample to lipopolysaccharide (LPS), a known stimulant of the immune response. When healthy cells are exposed to LPS, it prompts the production of tumor necrosis factor-alpha (TNFα), a type of protein called a cytokine that is part of the first line of defense in the body's innate immune system.

Sixteen critically injured subjects developed nosocomial infection. Those subjects had higher plasma interleukin (IL)-6 and IL-10 levels on post-trauma day (PTD) 1-2 compared to those who recovered without infection and outpatient controls. Ex vivo LPS-induced TNFα production capacity was lower in children on PTD 1-2 and over the first week following injury in those who went on to develop infection. The team found that patients who received a transfusion of blood that had been stored for more than two weeks prior to transfusion had a lower level of TNFα production than children whose transfused blood was less than two weeks old, regardless of the severity of their original injury.
The authors concluded that trauma-induced innate immune suppression is common in critically injured children and is associated with increased risks for the development of nosocomial infection. Potential exacerbating factors, including red blood cell transfusion and potential therapies for pediatric trauma-induced innate immune suppression are deserving of further study.

Mark W. Hall, MD, the senior author of the study said, “With a normal immune response, the body responds to pathogens and eliminates them before they cause an infection. But in many forms of critical illness, we see the immune system unable to do those things. Studies in adults with traumatic injuries have found that immune function is decreased in those patients, but this is the first data to show that the same thing happens in critically injured children.” The study was published on June 21, 2014, in the journal Shock.

Related Links:
Nationwide Children's Hospital




New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.